Syngene International Limited
NSE:SYNGENE.NS
Overview | Financials
Company Name | Syngene International Limited |
Symbol | SYNGENE.NS |
Currency | INR |
Price | 898.45 |
Market Cap | 360,541,968,080 |
Dividend Yield | 0.11% |
52-week-range | 607.65 - 945.25 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Jonathan Brittan Hunt |
Website | https://www.syngeneintl.com |
An error occurred while fetching data.
About Syngene International Limited
Syngene International Limited, a contract research and manufacturing company, provides drug discovery and development services in India, the United States, and internationally. The company provides discovery chemistry services, such as medicinal and synthetic chemistry, library and peptide synthesis, biomolecules, organic electronic materials, and computational and analytical chemistry; and discovery biology
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD